Darolutamide Now Approved as Single Agent for MCSPC ...Middle East

News by : (Medscape) -
The FDA approval is based on safety and efficacy demonstrated in the phase 3 ARANOTE trial, which evaluated darolutamide — without docetaxel chemotherapy — vs placebo. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Darolutamide Now Approved as Single Agent for MCSPC )

Also on site :

Most Viewed News
جديد الاخبار